Clinical Trial Update: Topical r-Hirudin ( Thrombexx ) Efficacy in Treatment of Haematomas [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update is provided for topical r-Hirudin (Thrombexx) evaluating its efficacy in treating haematomas; no results are reported and the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematoma

Drugs mentioned

• Thrombexx (r-Hirudin)

Snippet

Sponsor: MinaPharm Pharmaceuticals | Conditions: r-Hirudin (Thrombexx) Efficacy in Treatment of Haematomas | Phase 4 | Status: UNKNOWN